The study will be carried out in partnership with The GOG Foundation and the European Network of Gynecological Oncological ...

Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you.

Enhertu, Datroway and other antibody-drug conjugates developed by Daiichi Sankyo have made the company a leader in a ...

IHH Healthcare's subsidiary, NTK, accuses Daiichi Sankyo of damaging its interests through misleading statements regarding ...

Daiichi Sankyo and MSD have voluntarily withdrawn the biologics licence application (BLA) in the US for their HER3-directed ...

NTK accuses Daiichi Sankyo of misleading statements, causing damage in Fortis Healthcare open offer. JPY 200 billion damages ...

Northern TK Venture, a subsidiary of IHH Healthcare, has increased its legal claim against Daiichi Sankyo. The claim is now ...

In the release, the Japanese drugmaker said NTK’s claims that it interfered with the latter’s open offer are “without any merit or substance” and that the claims are “not sustainable”.

Patritumab deruxtecan was unable to significantly improve overall survival in patients with locally advanced or metastatic ...

Daiichi Sankyo Company Limited (OTC:DSNKY) and AstraZeneca (NASDAQ:AZN) announced promising results from 3 clinical trials: ...

Merck (NYSE:MRK) and Daiichi Sankyo (OTCPK:DSNKY) (OTCPK:DSKYF) announced Thursday the voluntary withdrawal of their U.S.